ECNS240920P29000
- 4.17
- 0.000.00%
iShares MSCI China Small-Cap ETF Newsroom
How will the usa's decision to impose tariffs on China's new energy industry affect? The plan was announced as early as May, and the market has long anticipated it.
①The plan to impose additional taxes on new energy imports from China by the USA was announced as early as May, and the market has already anticipated it; ② The tariff war cannot solve the problem of the loss of the real economy in the USA, and the USA is not the main destination for Chinese electric vehicle companies to expand overseas.
The market style continues to switch! The new energy fund track collectively revitalizes, paying close attention to the short-term speculation and taking the lead in breaking through the theme direction.
Track the entire lifecycle of the main sector.
With a compound annual growth rate of only 2.6% over the past five years, China's top 100 pharmaceutical companies are entering an adjustment period. How will the industry break through under internal and external pressures?
According to the data from China Meheco Group, in 2023, multiple operation indicators of the pharmaceutical industry's leading companies have declined. The compound annual growth rate of the top 100 pharmaceutical companies in the country in the past five years is only 2.6%, and the industry as a whole has entered the adjustment phase from the initial high-speed growth. Behind the weak growth, the health industry is also undergoing transformation: overseas licensing trades for innovative drugs have reached a new high, and leading companies are accelerating outward expansion...
Is the chain of pharmacies entering a "mini ice age"? H1 growth rate "downgrades", the industry's high-growth stores may reach turning point.
①The growth rate of total sales revenue of retail pharmacies has slowed down, and the competition continues to intensify. In the first half of this year, major leading chain drugstores found it difficult to increase revenue and profit; ②In the future, the focus of pharmacy competition will shift to product extension and services. According to Zhongkang Industry Research Institute, the growth rate of pharmaceuticals in all terminals is expected to decrease to 4.9% in 2024, compared to the decline in 2023.
Will you be eliminated if you don't go overseas? In the first half of the year, the proportion of innovative drug outbound business development accounted for about 80% | Industry Dynamics.
① At the 2024 New Investment Conference hosted by Forrester Sullivan, the issue of going global was highly favored by the participants. ② There is a new trend in the global expansion of innovative drugs in our country, such as the number of BDs going global surpassing License-in for the first time in 2023. ③ Some experts at the conference proposed a rational view and called for the need to strengthen internal capabilities, not just rely on enthusiasm.
A quick look | Hong Kong stock bull bear stock list for August released! Q2 performance impressive, GDS Holdings soared 56% within the month; Insurance stocks rallied strongly, China Re surged nearly 34%.
It is widely believed that the expected interest rate cut by the Federal Reserve in September has had a positive impact on the Hong Kong stock market. According to the latest market data, the Hang Seng Index has shown significant signs of rebound recently, indicating the market's volatility and gradual recovery of investor confidence.
Intraday quick view | The three major Hong Kong stock indexes opened low and moved lower, with the technology index falling more than 2%; Nongfu Spring plummeted more than 10%, while Anta performance surged nearly 7%.
Network technology stocks generally fell, with Baidu dropping more than 3%; auto stocks collectively declined, with Nio Inc dropping more than 4% and Li Auto dropping more than 5%; pharmaceutical stocks were active against the trend, with nt pharma surging nearly 17%.
US stock market preview: the three major futures oscillated slightly before the market, pdd holdings plunged nearly 17% after the performance; prospect of interest rate cut boosted gold prices, bringing joy to the gold bulls.
Hot technology stocks fluctuate before the market, with nvidia and Google slightly up; Xiaopeng Motors has increased its shareholding, and the stock price has risen nearly 4% before the market; expectations of interest rate cuts have ignited enthusiasm! The net inflow of funds into the bitcoin spot ETF hit a more than one-month high.
Hong Kong Stock Opportunity Tracking | Alibaba: Voluntarily converted to dual primary listings on the Hong Kong Stock Exchange; Baidu's subsidiary, Luobo Kuaipao, received approximately 0.899 million orders for Q2 autonomous driving, a 26% year-on-year in
Innovative products are emerging frequently, and the application of humanoid robots is accelerating.
Hong Kong Stock Opportunity Tracker | Xiaomi's second quarter revenue increased by nearly 30%, with a gross margin of 15.4% for autos; Latest exposure! Duan Yongping increased his holdings of Alibaba and Tencent.
cgn power's revenue in the first half of the year was approximately 39.377 billion yuan, a year-on-year increase of 0.3%; jd.com: as of August 20th, walmart no longer holds shares in the company.
Mid-day review | All three major indexes turned down collectively, coal industry concepts and petroleum stocks weakened, with Yancoal Australia falling nearly 20% after their performance announcement.
Futu news on August 20th, Hong Kong stocks opened high and then fell collectively. As of the time of publication, Hang Seng Index (800000.HK) fell by 0.34%, Hang Seng China Enterprises Index (800100.HK) fell by 0.46%, and Hang Seng Tech Index (800700.HK) fell by 0.21%. As for sectors, network technology stocks rose and fell, Baidu and Bilibili rose by more than 1%, NetEase rose by 1%, JD.com and Kuaishou rose slightly; Alibaba fell by more than 1%, Sensetime and Tencent fell by nearly 1%. New energy automobile stocks rose across the board, with NIO Inc, Li Auto Inc, BYD Company and Xpeng all rising.
China Stops Releasing Real-time Foreign Fund Flow Data
New energy fund "battle" on the 100,000 yuan track | Frontline.
The penetration rate of new energy vehicles has exceeded 50%, and the price war among car companies has spread to the 100,000 yuan level. In the first half of the year, car companies that exchanged quantity for price paid a high price.
Intraday overview | Hong Kong stocks fluctuated slightly, wind power and eco-friendly concept stocks rose, bilibili dropped more than 7%, leading the decline in network technology stocks.
Hang Seng Index rose 0.17%, Hang Seng Tech Index fell 0.23%. Network technology stocks generally weakened, Bilibili fell more than 7%, SenseTime and Meituan fell more than 2%, Baidu fell more than 1%, while Kuaishou and JD.com followed suit; Xiaomi Group rose nearly 1%.
Policy is promoting the full-chain development of hydrogen energy 'production, storage, transportation and utilization', and the domestic hydrogen energy market is expected to explode.
The "Opinions on Accelerating the Comprehensive Green Transformation of Economic and Social Development" issued by the CPC Central Committee and the State Council on August 11 proposes to promote the full-chain development of hydrogen energy "production, storage, transmission and use". According to CCTV Finance, since the beginning of this year, export orders for core equipment for producing hydrogen gas, such as electrolytic tanks, have rapidly increased. Industry insiders told reporters that green hydrogen projects under construction and planned in many regions of the world are showing significant growth.
Over 400 pharmaceuticals selected! The preliminary list of the 2024 National Drug Reimbursement List has been published. Experts predict that the threshold for innovative drugs may be lowered.
This year, 440 pharmaceuticals were preliminarily reviewed and included in the drug list for national medical insurance negotiations, with 196 and 244 pharmaceuticals inside and outside the catalog respectively. Many of the applied drugs are innovative drugs that will be launched in June. Several of them have preemptively reduced their prices to increase the probability of successful negotiations. Based on supportive policies, experts predict that the threshold for access to innovative drugs may be lowered this year, and the number of them may increase.
A quick view during trading hours: The three major Hong Kong stock indices have turned upward, with Kuaishou and Tencent rising by more than 2%, and Netease and Alibaba rising by more than 1%.
Auto stocks fell, with NIO down 3%, BYD Company down over 2%; Golden industrial concept performed weakly, with Zhaojin Mining down over 6%; mainland education stocks fell today, with New Oriental down over 6%.
The list of initial review of the national dialogue in 2024 has been announced! Many heavyweight innovative drugs are listed, and almost all CAR-T varieties are gathered. Will there be breakthroughs? | Industry observation
This evening, the National Medical Insurance Bureau announced the list of drugs that passed the preliminary review of the national negotiations this year. The bureau received 626 applications from enterprises, and 440 drugs passed the preliminary review. Several heavy-weight innovative drugs have been approved by the wire or reduced in price, which is considered by the industry as the most important channel for the commercial realization of innovative drugs through medical insurance eligibility. Almost all types of domestic CAR-T are gathered, and experts predict that there may be breakthroughs this year.
Core product sales guidelines driven by the expansion of medical insurance. Zai lab: striving to achieve profitability by the end of 2025.
The second quarter sales of intravenous Agamod α injection were $23.2 million, driving Zai Lab's product revenue to surpass $0.1 billion. The expected annual revenue of this product has been raised to over $80 million. Enterprise employees revealed that including subcutaneous injection Agamod, three new products have not yet achieved commercial sales since they were recently approved.
At midday review, Hong Kong stocks collectively rose, with the three major indices up more than 1%; Japan ETF strengthened, and ChinaAMC MSCI Japan Hedged to USD ETF rose nearly 7%.
The components of the Science and Technology Index rose across the board, with Weibo up nearly 7%, Eastbuy up more than 5%, Ctrip Group up nearly 4%, and Tongcheng Travel up more than 3%.